Updates in the Treatment of HR+/HER2- Breast Cancer - Episode 15
Impact of ADC Toxicities and Clinical Decision-Making for mBC
Panelists discuss adverse events associated with antibody-drug conjugates (ADCs) that impact clinical decision-making and share strategies for managing these adverse events.
Video content above is prompted by the following:
- Dr. Bardia to All Panelists: Are there any adverse events (AEsadverse events) seen with ADCs that impact your clinical decision-making?
- What strategies do you employ for management?
Related Content:
